Insider Trading History of Emany Sravan Kumar

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Emany Sravan Kumar since 2022. This trader's CIK number is 1897662. At the time of last reporting, Emany Sravan Kumar was the Chief Financial Officer of Beam Therapeutics Inc.. (stock ticker symbol BEAM). Also see all insider trading activities at Beam Therapeutics Inc..

Note that in the past Emany Sravan Kumar also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ironwood Pharmaceuticals Inc (IRWD) by Emany Sravan Kumar

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 IRWD 10,684 $100,215 11,001 $44,884 0 $0
2023 IRWD 36,072 $300,119 0 $0 0 $0
2022 IRWD 0 $0 13,156 $152,082 0 $0

Yearly summary of insider trading at Beam Therapeutics Inc. (BEAM) by Emany Sravan Kumar

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 BEAM 0 $0 6,294 $170,567 0 $0


Insider trading activities at 2 companies by Emany Sravan Kumar:

1. Ironwood Pharmaceuticals Inc (IRWD)

2. Beam Therapeutics Inc. (BEAM)

Table 1. Insider trading of Ironwood Pharmaceuticals Inc (IRWD) by Emany Sravan Kumar

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-18 IRWD Sale 11,001 4.08 44,884
2024-03-04 IRWD Buy 10,684 9.38 100,215
2023-09-15 IRWD Buy 36,072 8.32 300,119
2022-11-21 IRWD Sale 6,578 11.56 76,041
2022-11-21 IRWD Sale 6,578 11.56 76,041

Table 2. Insider trading of Beam Therapeutics Inc. (BEAM) by Emany Sravan Kumar

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-12-31 BEAM Sale 6,294 27.10 170,567

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Emany Sravan Kumar (Chief Financial Officer of Beam Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.